{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:29:11Z","timestamp":1770510551057,"version":"3.49.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IADT"],"published-print":{"date-parts":[[2012,9,2]]},"DOI":"10.2174\/187152812803250980","type":"journal-article","created":{"date-parts":[[2012,10,14]],"date-time":"2012-10-14T23:58:15Z","timestamp":1350259095000},"page":"351-363","source":"Crossref","is-referenced-by-count":11,"title":["Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II"],"prefix":"10.2174","volume":"11","author":[{"given":"Albert","family":"J. Czaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Inflammation & Allergy-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/103202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:53:59Z","timestamp":1448290439000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5281&volume=11&issue=5&spage=351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,2]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187152812803250980","relation":{},"ISSN":["1871-5281"],"issn-type":[{"value":"1871-5281","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,2]]}}}